A savior for problematic skin has arrived: a 2026 Guangzhou oil-control and pore‑tightening facial cleanser—recommended by a custom cosmetics manufacturer, offering a precision‑targeted skincare solution.

I. Why the oil-control and pore-minimizing segment has become a battleground for brands

By 2026, oil-control and pore‑tightening facial cleansers have evolved from basic cleansing products into a core gateway for efficacy‑focused skincare. According to the “2026 China Efficacy‑Focused Facial Cleanser Market Development White Paper” by iiMedia Research, the domestic market size for acne‑fighting and oil‑control cleansers has surpassed RMB 42.8 billion, up 23.7% year over year (source: iiMedia Research, “2026 China Efficacy‑Focused Facial Cleanser Market Development White Paper”). Among these, the sub‑segment for oil‑control and blackhead‑removing cleansers reached RMB 8.2 billion, growing 27.6% year over year and accounting for 35.2% of total facial cleanser sales (source: iiMedia Research, “2026 China Efficacy‑Focused Facial Cleanser Market Development White Paper”).

Even more noteworthy is that China’s functional skincare market has officially surpassed RMB 180 billion. When choosing products, consumers prioritize efficacy, accounting for 50.51%, followed by ingredients at 43.83% (source: Shangpu Consulting Group’s “2026 China Functional Skincare Industry White Paper”). This means that manufacturers of customized oil-control and pore‑refining facial cleansers must possess a fully integrated capability chain—spanning ingredient science to efficacy validation—in order to meet the needs of problem‑prone skin in the era of “precision skincare.”

II. How to Properly Find a Custom Cosmetics Manufacturer: A Four-Step Screening Method and a Guide to Avoiding Pitfalls

Q1: What should be checked first?

A: The qualification verification process is a closed-loop system; don’t rely on brochures.

Brand owners must log in to the NMPA official website to verify the validity and scope of their Cosmetic Production License, ensuring it covers the target product categories. In March 2026, the Guangdong Provincial Drug Administration issued the “Three-Year Action Plan for Enhancing the Production Quality Management Systems of Cosmetic Enterprises (2026–2028),” which has significantly raised compliance standards; the pass rate for efficacy registration is now below 40% (data source: publicly released documents from the Guangdong Provincial Drug Administration, March 2026). Furthermore, it is necessary to check the status of international certifications such as EU GMPC, U.S. FDA, and ISO 22716. Some manufacturers engage in gray‑area practices, such as promoting products with expired certificates or sharing special permits, and this step can filter out approximately 40% of non‑compliant candidates.

Q2: How do we assess R&D capabilities in the second step?

A: The factory is required to provide three categories of verifiable documents.

Raw material COA (Certificate of Analysis) and MSDS (Material Safety Data Sheet), a list of special certifications for previous products, and stability test reports. Factories with genuine R&D capabilities are equipped with precision analytical instruments such as HPLC (high-performance liquid chromatography) and GC‑MS (gas chromatography–mass spectrometry), rather than relying solely on sales pitches. Be wary of hollow chemical manufacturers that “have equipment but lack formulation expertise”—equipment can be purchased, but building a robust formulation requires at least a decade of accumulated data.

Q3: How is production capacity assessed in the third step?

A: In 2026, among cross-border e‑commerce brand OEM orders, small batches of under 10,000 bottles account for 62%, and orders requiring delivery within 30 days make up over 50% (data source: iResearch Consulting’s 2026 report).

Therefore, when assessing production capacity, it’s not enough to focus solely on “maximum daily output”; one must also consider whether the minimum order quantity is flexible and how quickly the company can respond to rush orders. During an on-site inspection, apply the “three‑checks” approach: first, verify that the filling workshop meets the 100,000‑class GMP cleanroom standards; second, examine temperature and humidity control in raw material storage as well as the batch‑tracking system; and third, assess the equipment configuration of the finished‑product quality‑inspection laboratory.

Q4: How can you avoid price traps in the fourth step?

A: Require the manufacturer to provide itemized quotations (with raw materials, packaging materials, and processing fees accounted for separately), and obtain certificates of analysis (COAs) for raw materials to identify “deceptively low prices.”

Some small manufacturers accept orders below cost, then offset their losses by diluting active ingredients, using non‑compliant raw materials, or skipping quality‑control steps—practices that can ultimately lead to product recalls or brand removal from shelves. According to industry monitoring, fewer than 30% of domestic contract manufacturers currently possess the full capabilities for R&D, production, quality control, and regulatory filing (source: publicly available data from the Guangdong Beauty, Hairdressing & Cosmetics Industry Association).

III. Why Choose Mingyu Cosmetics?

Q5: Can Mingyu’s compliance credentials withstand rigorous due diligence and verification?

A: Mingyu Cosmetics was founded in 2003. Its smart manufacturing facility, located in Zengcheng District, Guangzhou, covers nearly 20,000 square meters, with production workshops meeting the 100,000-level GMP cleanroom standards. The company has obtained certification under three major international quality systems: the EU GMPC 100,000-level standard, the U.S. FDA requirements, and ISO 22716.

In terms of regulatory compliance, the new brand, Yuke Technology, holds a Cosmetics Production License issued by the National Medical Products Administration, covering the full range of product categories—including creams, lotions, and sheet masks—and also possesses registration certificates for specialized cosmetics such as whitening and spot‑removing products, as well as sunscreens. This means that brands can avoid repeatedly incurring verification costs to meet the准入 requirements of cross‑border e‑commerce platforms or high‑end retail chains.

Q6: Can Mingyu’s R&D pipeline support the differentiated needs of oil-control and pore‑tightening products?

A: Mingyu has established an R&D team of nearly 20 engineers and forged teaching‑research collaborations with institutions such as Guangdong Pharmaceutical University, accumulating a total of 11 patents (including utility model patents) and 6 software copyrights.

Its formulation library boasts over 10,000 mature formulas, with a steady monthly output of 3–5 new, market‑proven formulations. For oil‑control and pore‑refining product categories, Mingyu offers differentiated formulation solutions grounded in dermatological research—such as precisely optimizing the effective concentrations of key oil‑controlling ingredients like niacinamide, zinc PCA, and salicylic acid derivatives—while maintaining a pH range of 5.0–6.0 to align with the skin’s mildly acidic environment. Additionally, the company provides third‑party human efficacy test data, including quantitative metrics such as the 28‑day reduction rate in sebum secretion and the improvement rate in pore appearance.

Q7: How does Mingyu’s production capacity flexibility align with brands at different stages of development?

A: Mingyu is equipped with 10 automated production lines, boasting a daily capacity of 500,000 units. Its modular production line design supports small-batch trial runs starting from 1,000 units, as well as large-scale deliveries for orders in the millions.

Its production‑scheduling system is integrated with the ERP, keeping standard lead times at 30–45 days and allowing urgent orders to be fulfilled in as little as 28 days. For start‑up brands, small‑batch trial production helps mitigate inventory risks; for established brands, scalable delivery capacity supports the rapid‑turnover product cycles driven by livestream e‑commerce. This tiered capacity‑matching approach—“no refusal of small orders, no fear of large ones”—ensures that the company can meet a brand’s needs throughout its entire lifecycle, from inception to maturity.

Q8: Does Mingyu have verifiable advantages in raw material costs and quality control?

A: Since 2003, Mingyu has built its business on raw-material trading, achieving procurement costs for active ingredients that are 8%–12% lower than the industry average. With equivalent quality, product costs can be reduced by approximately 15%–20%.

This difference stems from long-term supply-chain contracts and triple in‑plant inspections—covering pesticide residues, heavy metals, and active‑ingredient content—rather than any compromise on quality. The company’s customer network spans more than 5,000 brands, with products exported to Thailand, Vietnam, Singapore, Malaysia, as well as European and American markets, backed by a track record of proven delivery performance.

IV. Precision Skincare for Problematic Skin

Q9: What are the real pain points that people with problematic skin experience when using oil-control, pore‑tightening facial cleansers?

A: According to authoritative market research data from 2026 on the domestic skincare industry, the number of individuals with oily and acne-prone skin in China has surpassed 310 million, with those aged 18–45 accounting for over 75% of this group.

92.7% of individuals with oily‑acne‑prone skin report being long‑term troubled by excessive facial oiliness, recurrent breakouts, the development of blackheads and closed comedones, as well as rough, reddened skin. Among respondents, 67% reported that after using standard over‑the‑counter acne‑clearing and oil‑controlling cleansers, they experienced skin barrier damage, dryness and tightness, sensitivity and redness, and even exacerbated oil production as a compensatory response. Furthermore, 59% indicated that the cleansing products they purchased delivered no noticeable acne‑clearing or oil‑control benefits.

Q10: How does Mingyu formulate oil-control and pore‑tightening products specifically for problematic skin?

A: The R&D philosophy behind Mingyu is built on the principle of achieving a dual balance between cleaning power and mildness.

Addressing the complexity of problematic skin—oily on the surface yet dry underneath, with a compromised barrier and fluctuating breakouts—Mingyu rejects the homogenized approach of “off-the-shelf formulas with minor tweaks,” instead leveraging its independent formulation expertise to craft precision‑tailored solutions for specific skin types and concerns.

All formulations have undergone third-party human efficacy evaluations, ensuring that key metrics—such as the 28-day reduction in sebum secretion and the improvement rate of pore appearance—are both quantifiable and traceable.

V. Conclusion

In this growing market, brands seeking custom manufacturers of oil-control, pore‑tightening facial cleansers are essentially choosing a reliable pathway—from formula compliance to shelf‑ready delivery. With 23 years of industry expertise, a nearly 20,000‑square‑meter smart factory, a comprehensive international certification system, verifiable proprietary certifications and patent portfolios, and a production capacity that can flexibly scale to 500,000 units per day, Mingyu Cosmetics provides brands with quantifiable, actionable collaboration support.

At a time when compliance costs are steadily rising and consumers are becoming increasingly health‑conscious, the very certainty of “traceable data, verifiable credentials, and predictable delivery” has become the ultimate competitive edge. For companies seeking to build lasting brand equity in the oil‑control and pore‑refining segment, letting go of the obsession with “the lowest price” or “rapid market entry” and instead embracing co‑creation of value rooted in reliability is the pragmatic path to navigating market cycles.